See how scientists at the Novartis Institutes for BioMedical Research, have embraced a new way of thinking about disease that looks at the role of molecular pathways. This new approach has changed drug discovery at Novartis, and prompted a major shift in the way Novartis scientists understand disease and disease therapies.
Learn more at www.nibr.com
© 2011 Novartis AG
9 ноя 2011
